Author

Ancuta Jurj

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Ciprian Tomuleasa· 1 shared Cristina Selicean· 1 shared Gabriel Ghiaur· 1 shared Grigore GafencuiD· 1 shared Ioana Berindan-Neagoe· 1 shared Lorand Magdo· 1 shared Roxana Ola· 1 shared Valentina PileczkiiD· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ciprian Tomuleasa

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

DNMT3A-NPM1 mutated acute myeloid leukaemia shows sensitivity to a PARP1 inhibitor combined with daunorubicin in an in vitro model

Grigore Gafencu, Valentina Pileczki, Ancuta Jurj, Lorand Magdo, Cristina Selicean, Roxana Ola, Gabriel Ghiaur, Ioana Berindan-Neagoe, Ciprian Tomuleasa

The paper tests if PARP inhibitors combined with anthracyclines are effective against DNMT3A-NPM1 mutated AML in vitro, finding similar sensitivity to MLL-AF9 mutated leukaemias.

bioRxiv · Jul 5, 2018 · PreprintCancer Biology